BioSpace News Archive

Hagens Berman Sobol Shapiro LLP notifies investors in CareDx, Inc. of the firm’s investigation of possible disclosure violations.

Altaire Pharmaceuticals, Inc., announces that it is voluntarily recalling the Over-the-Counter drug products and lots, within expiry, sold by Accutome, Focus Laboratories, Grandall Distributing Co.

Antibe Therapeutics Inc. filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.

July 16, 2019 08:00 AM Eastern Daylight Time--Tishman Speyer, one of the world’s leading developers, owners, operators and asset managers of first-class real estate, and Bellco Capital (“Bellco”), an investment firm founded by biotechnology entrepreneurs Drs. Rebecka and Arie Belldegrun, have formed Breakthrough Properties (“Breakthrough”).